{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:23:03Z","timestamp":1783689783528,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Time to sputum culture conversion is critical for follow-up treatment effectiveness in multidrug-resistant tuberculosis patients. However, the evidence regarding time to culture conversion, treatment outcomes, and the associated factors was sparse and inconsistent.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to determine the time to culture conversion, treatment outcomes, and associated factors among rifampicin-resistant and multidrug-resistant tuberculosis cases in the Sidama region from April 1 to December 31, 2024.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a retrospective follow-up study of 346 patients who enrolled between January 2013 and June 2024. We collected data from patients\u2019 medical records using a standardized form, entered the data, and analyzed it using Stata 16.1 software. We performed the analysis using the Kaplan-Meier model for time to culture conversion, Weibull distribution gamma frailty, and logistic regression models to assess factors associated with time to culture conversion and treatment outcomes, respectively. We considered an adjusted hazard or odds ratio with a 95% CI and a p-value\u2009<\u20090.05 to determine significance.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the participants, 302 (87.3%) achieved culture conversion in a median time of 76 days (95% CI: 71\u201379 days). Patients with a history of previous loss to follow-up experienced an approximately fivefold delay in culture conversion (AHR\u2009=\u20090.2; 95% CI: 0.1\u20130.6; p\u2009=\u20090.001), while relapse cases had a twofold delay (AHR\u2009=\u20090.5; 95% CI: 0.2\u20130.9; p\u2009=\u20090.02) compared with new patients. The treatment success rate was 234\/346 (67.6%). Female patients had higher odds of achieving a favorable treatment outcome (AOR\u2009=\u20091.8; 95% CI: 1.0\u20133.3; p\u2009=\u20090.04), whereas patients who experienced culture reversion had significantly lower odds of a favorable outcome (AOR\u2009=\u20090.05; 95% CI: 0\u20130.4; p\u2009=\u20090.001).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The majority of patients experienced culture conversion within three months. However, patients with a history of loss to follow-up and relapse experienced delayed culture conversion. These findings highlight the urgent need to improve patient adherence.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0327705","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:30:48Z","timestamp":1776101448000},"page":"e0327705","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time to sputum culture conversion, treatment outcomes, and associated factors among rifampicin-resistant or multidrug-resistant tuberculosis patients in the Sidama region, Ethiopia: A retrospective follow-up study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0740-5002","authenticated-orcid":true,"given":"Wolde Abreham","family":"Geda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede Tefera","family":"Betru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"pone.0327705.ref001","year":"2024"},{"key":"pone.0327705.ref002","unstructured":"World Health Organization. WHO TB dashboard. World Health Organization. https:\/\/data.who.int\/dashboards\/tuberculosis\/. 2025. Accessed 2025 February 11."},{"key":"pone.0327705.ref003","year":"2023"},{"issue":"6","key":"pone.0327705.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199320","article-title":"Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study","volume":"13","author":"T Yihunie Akalu","year":"2018","journal-title":"PLoS One"},{"issue":"50","key":"pone.0327705.ref005","article-title":"Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study","volume":"99","author":"Q Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"pone.0327705.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198080","article-title":"Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia","volume":"13","author":"A Shibabaw","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0327705.ref007","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12879-018-3021-0","article-title":"Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China","volume":"18","author":"Q Liu","year":"2018","journal-title":"BMC Infect Dis"},{"key":"pone.0327705.ref008","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment \u2013 drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2020"},{"issue":"1","key":"pone.0327705.ref009","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1038\/s41467-024-48077-8","article-title":"Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis","volume":"15","author":"S Kho","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0327705.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062034","article-title":"Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania","volume":"8","author":"SG Mpagama","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"pone.0327705.ref011","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5588\/ijtld.13.0602","article-title":"Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia","volume":"18","author":"FA Putri","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"pone.0327705.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277642","article-title":"Predictors of sputum culture conversion time among MDR\/RR TB patients on treatment in a low-income setting","volume":"17","author":"MD Meshesha","year":"2022","journal-title":"PLoS One"},{"key":"pone.0327705.ref013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/IDR.S153499","article-title":"Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis","volume":"11","author":"L Lv","year":"2018","journal-title":"Infect Drug Resist"},{"key":"pone.0327705.ref014","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2147\/IDR.S293461","article-title":"Malnutrition is associated with delayed sputum culture conversion among patients treated for MDR-TB","volume":"14","author":"AB Bade","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0327705.ref015","first-page":"111","article-title":"Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital","volume":"34","author":"R Ncha","year":"2019","journal-title":"S Afr J Infect Dis"},{"key":"pone.0327705.ref016","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.2147\/IDR.S343672","article-title":"A retrospective comparative study on median time to sputum culture conversion in multi-drug resistant pulmonary tuberculosis patients in pastoral and non-pastoral settings in Southeast Oromia, Ethiopia","volume":"14","author":"A Megerso","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"9","key":"pone.0327705.ref017","article-title":"Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa","volume":"8","author":"JCM Brust","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"pone.0327705.ref018","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.5588\/ijtld.18.0649","article-title":"What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?","volume":"23","author":"M Bastard","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"pone.0327705.ref019","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/tmi.13245","article-title":"Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda","volume":"24","author":"CM Muvunyi","year":"2019","journal-title":"Trop Med Int Health"},{"key":"pone.0327705.ref020","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2147\/IDR.S413495","article-title":"Time to sputum culture conversion and its predictors among multidrug resistant tuberculosis patients in tigray, Northern Ethiopia: Retrospective cohort study","volume":"16","author":"L Weldemhret","year":"2023","journal-title":"Infect Drug Resist"},{"issue":"4","key":"pone.0327705.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094890","article-title":"Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia","volume":"9","author":"MJ Magee","year":"2014","journal-title":"PLoS One"},{"key":"pone.0327705.ref022","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.2147\/IDR.S250878","article-title":"Predictors of Time to sputum culture conversion among drug-resistant tuberculosis patients in Oromia Region Hospitals, Ethiopia","volume":"13","author":"Y Tekalegn","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"12","key":"pone.0327705.ref023","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.5588\/ijtld.16.0096","article-title":"Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis","volume":"20","author":"B Velayutham","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0327705.ref024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijid.2020.06.029","article-title":"Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis","volume":"98","author":"MA Assemie","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pone.0327705.ref025","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4081\/monaldi.2021.1679","article-title":"Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019\u20132020","volume":"91","author":"T Avaliani","year":"2021","journal-title":"Monaldi Arch Chest Dis"},{"issue":"3","key":"pone.0327705.ref026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/tmi.12826","article-title":"Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia","volume":"22","author":"KA Alene","year":"2017","journal-title":"Trop Med Int Health"},{"issue":"1","key":"pone.0327705.ref027","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1186\/s12879-021-06743-y","article-title":"High rates of culture conversion and low loss to follow-up in MDR-TB patients managed at Regional Referral Hospitals in Uganda","volume":"21","author":"MK Martin","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"2","key":"pone.0327705.ref028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262318","article-title":"Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia","volume":"17","author":"MK Wakjira","year":"2022","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:30:57Z","timestamp":1776101457000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327705"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0327705","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}